APTO Aptose Biosciences Inc.

Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology.

$5.24  +0.07 (1.26%)
As of 04/09/2021 15:59:43 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  
IPO date:  10/07/2014
Outstanding shares:  88,881,737
Average volume:  11,294,426
Market cap:   $466,629,119
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    03835T101
ISIN:        
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   10.63
PS ratio:   0.00
Return on equity:   -46.45%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy